HK1198741A1 - New (trimethoxyphenylamino)pyrimidinyl formulations () - Google Patents
New (trimethoxyphenylamino)pyrimidinyl formulations ()Info
- Publication number
- HK1198741A1 HK1198741A1 HK14112235.4A HK14112235A HK1198741A1 HK 1198741 A1 HK1198741 A1 HK 1198741A1 HK 14112235 A HK14112235 A HK 14112235A HK 1198741 A1 HK1198741 A1 HK 1198741A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trimethoxyphenylamino
- pyrimidinyl
- formulations
- new
- pyrimidinyl formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512621P | 2011-07-28 | 2011-07-28 | |
| PCT/GB2012/051791 WO2013014454A1 (en) | 2011-07-28 | 2012-07-26 | New (trimethoxyphenylamino)pyrimidinyl formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1198741A1 true HK1198741A1 (en) | 2015-06-05 |
Family
ID=46875902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14112235.4A HK1198741A1 (en) | 2011-07-28 | 2014-12-04 | New (trimethoxyphenylamino)pyrimidinyl formulations () |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8771648B2 (es) |
| EP (1) | EP2736487B1 (es) |
| JP (1) | JP6019116B2 (es) |
| KR (2) | KR102090440B1 (es) |
| CN (1) | CN103826610B (es) |
| AR (1) | AR087371A1 (es) |
| AU (1) | AU2012288632B2 (es) |
| BR (1) | BR112014001999B1 (es) |
| CA (1) | CA2843138C (es) |
| CY (1) | CY1122596T1 (es) |
| DK (1) | DK2736487T3 (es) |
| EA (1) | EA028432B1 (es) |
| ES (1) | ES2710423T3 (es) |
| HK (1) | HK1198741A1 (es) |
| HR (1) | HRP20190186T1 (es) |
| HU (1) | HUE042611T2 (es) |
| LT (1) | LT2736487T (es) |
| MX (1) | MX339685B (es) |
| PL (1) | PL2736487T3 (es) |
| PT (1) | PT2736487T (es) |
| RS (1) | RS58433B1 (es) |
| SI (1) | SI2736487T1 (es) |
| TR (1) | TR201901792T4 (es) |
| TW (1) | TW201311251A (es) |
| UY (1) | UY34223A (es) |
| WO (1) | WO2013014454A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8163902B2 (en) * | 2006-11-21 | 2012-04-24 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| PL2736487T3 (pl) | 2011-07-28 | 2019-06-28 | Rigel Pharmaceuticals, Inc. | Nowe preparaty (trimetoksyfenyloamino)pirymidynylowe |
| CA2979990C (en) | 2015-04-02 | 2023-03-28 | Stora Enso Oyj | An activated lignin composition, a method for the manufacturing thereof and use thereof |
| US20180296579A1 (en) | 2015-04-24 | 2018-10-18 | Rigel Pharmaceuticals, Inc. | Methods of treating ibrutinib-resistant disease |
| BR112023001041A2 (pt) * | 2020-07-24 | 2023-03-07 | Dsm Ip Assets Bv | Comprimidos de dissolução rápida |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| MXPA05001096A (es) | 2002-07-29 | 2005-11-23 | Rigel Pharmaceuticals Inc | Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina. |
| PL1656372T3 (pl) | 2003-07-30 | 2013-08-30 | Rigel Pharmaceuticals Inc | Związki 2,4-pirymidynodiaminy do stosowania w leczeniu lub zapobieganiu chorobom autoimmunologicznym |
| DK1663242T3 (da) | 2003-08-07 | 2011-08-01 | Rigel Pharmaceuticals Inc | 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler |
| WO2006012502A2 (en) * | 2004-07-23 | 2006-02-02 | Rigel Pharmaceuticals, Inc. | Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| US20060069110A1 (en) * | 2004-09-27 | 2006-03-30 | Andersen Denise L | Substituted heterocyclic compounds and methods of use |
| PT1856135E (pt) * | 2005-01-19 | 2010-02-26 | Rigel Pharmaceuticals Inc | Pró-fármacos de compostos 2,4-pirimidinodiamina e suas utilizações |
| US8227455B2 (en) | 2005-04-18 | 2012-07-24 | Rigel Pharmaceuticals, Inc. | Methods of treating cell proliferative disorders |
| EP1959961A2 (en) * | 2005-12-06 | 2008-08-27 | Rigel Pharmaceuticals, Inc. | Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| PL1984357T3 (pl) * | 2006-02-17 | 2014-03-31 | Rigel Pharmaceuticals Inc | Związki 2,4-pirymidynodiaminy do leczenia lub zapobiegania chorób autoimmunologicznych |
| US20090048214A1 (en) * | 2006-11-15 | 2009-02-19 | Rigel Pharmaceuticals, Inc | Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds |
| US8163902B2 (en) * | 2006-11-21 | 2012-04-24 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| US20090012045A1 (en) * | 2007-06-26 | 2009-01-08 | Rigel Pharmaceuticals, Inc. | Methods of Treating Cell Proliferative Disorders |
| WO2009029682A1 (en) * | 2007-08-28 | 2009-03-05 | Rigel Pharmaceuticals, Inc. | Combination therapy with syk kinase inhibitor |
| KR101663838B1 (ko) * | 2007-11-07 | 2016-10-07 | 리겔 파마슈티칼스, 인크. | 물 격리제를 사용한 습윤 과립화법 |
| JP5586482B2 (ja) | 2008-02-22 | 2014-09-10 | ライジェル ファーマシューティカルズ， インコーポレイテッド | アテローム性動脈硬化症の治療のための２，４−ピリミジンジアミンの使用 |
| UA108077C2 (xx) | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну | |
| WO2011009075A2 (en) | 2009-07-17 | 2011-01-20 | Rigel Pharmaceuticals, Inc. | Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| US8389515B2 (en) | 2009-11-20 | 2013-03-05 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and prodrugs and their uses |
| EP2558474B1 (en) | 2010-04-13 | 2015-11-25 | Rigel Pharmaceuticals, Inc. | 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| PL2736487T3 (pl) | 2011-07-28 | 2019-06-28 | Rigel Pharmaceuticals, Inc. | Nowe preparaty (trimetoksyfenyloamino)pirymidynylowe |
-
2012
- 2012-07-26 PL PL12759802T patent/PL2736487T3/pl unknown
- 2012-07-26 MX MX2014001065A patent/MX339685B/es active IP Right Grant
- 2012-07-26 ES ES12759802T patent/ES2710423T3/es active Active
- 2012-07-26 PT PT12759802T patent/PT2736487T/pt unknown
- 2012-07-26 CN CN201280046605.3A patent/CN103826610B/zh active Active
- 2012-07-26 RS RS20190146A patent/RS58433B1/sr unknown
- 2012-07-26 BR BR112014001999-1A patent/BR112014001999B1/pt active IP Right Grant
- 2012-07-26 KR KR1020197027074A patent/KR102090440B1/ko active IP Right Grant
- 2012-07-26 DK DK12759802.7T patent/DK2736487T3/en active
- 2012-07-26 EP EP12759802.7A patent/EP2736487B1/en active Active
- 2012-07-26 CA CA2843138A patent/CA2843138C/en active Active
- 2012-07-26 TR TR2019/01792T patent/TR201901792T4/tr unknown
- 2012-07-26 UY UY0001034223A patent/UY34223A/es unknown
- 2012-07-26 AU AU2012288632A patent/AU2012288632B2/en active Active
- 2012-07-26 KR KR1020147004810A patent/KR102024120B1/ko active IP Right Grant
- 2012-07-26 SI SI201231519T patent/SI2736487T1/sl unknown
- 2012-07-26 LT LTEP12759802.7T patent/LT2736487T/lt unknown
- 2012-07-26 JP JP2014522154A patent/JP6019116B2/ja active Active
- 2012-07-26 EA EA201490363A patent/EA028432B1/ru unknown
- 2012-07-26 WO PCT/GB2012/051791 patent/WO2013014454A1/en active Application Filing
- 2012-07-26 HU HUE12759802A patent/HUE042611T2/hu unknown
- 2012-07-27 TW TW101127261A patent/TW201311251A/zh unknown
- 2012-07-27 US US13/559,805 patent/US8771648B2/en active Active
- 2012-07-27 AR ARP120102755A patent/AR087371A1/es not_active Application Discontinuation
-
2014
- 2014-05-29 US US14/290,494 patent/US8951504B2/en active Active
- 2014-12-04 HK HK14112235.4A patent/HK1198741A1/xx unknown
-
2019
- 2019-01-29 HR HRP20190186TT patent/HRP20190186T1/hr unknown
- 2019-02-06 CY CY20191100159T patent/CY1122596T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI563077B (en) | Cleaning formulations | |
| HRP20181896T1 (hr) | Farmaceutske formulacije | |
| IL227896B (en) | Freeze-dried formulations | |
| HRP20190186T1 (hr) | Nove formulacije (trimetoksifenilamino)pirimidinila | |
| EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
| SI2753311T1 (sl) | Formulacije antioksidanta | |
| EP2934482A4 (en) | ADMINISTRATIVE FORMULATIONS | |
| GB201114725D0 (en) | Ophthalmic formulations | |
| PT2908835T (pt) | Formulações estáveis | |
| EP2729164A4 (en) | FORMULATIONS STABILIZING PROTEINS | |
| EP2782585A4 (en) | ANTIVIRAL PREPARATIONS | |
| GB201110278D0 (en) | Formulations | |
| GB201221125D0 (en) | Pharmaceutial formulations | |
| GB201111578D0 (en) | Pharmeutical formulations | |
| GB201111013D0 (en) | Formulations | |
| GB201107626D0 (en) | Formulations | |
| GB201107627D0 (en) | Formulations | |
| GB201105410D0 (en) | Formulations | |
| GB201105360D0 (en) | Formulations | |
| GB201104048D0 (en) | Formulations | |
| GB201104049D0 (en) | Formulations | |
| GB201102795D0 (en) | Formulations | |
| GB201206178D0 (en) | Formulations | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201103767D0 (en) | Cosmetic formulations |